<SEC-DOCUMENT>0001193125-26-215721.txt : 20260511
<SEC-HEADER>0001193125-26-215721.hdr.sgml : 20260511
<ACCEPTANCE-DATETIME>20260511073617
ACCESSION NUMBER:		0001193125-26-215721
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20260511
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260511
DATE AS OF CHANGE:		20260511

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Intellia Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001652130
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				364785571
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37766
		FILM NUMBER:		26960891

	BUSINESS ADDRESS:	
		STREET 1:		40 ERIE STREET
		STREET 2:		SUITE 130
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		857-285-6200

	MAIL ADDRESS:	
		STREET 1:		40 ERIE STREET
		STREET 2:		SUITE 130
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ntla-20260511.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2026-05-08T17:36:47.2732+00:00 -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ntla="http://intelliatx.com/20260511" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_a664bd6f-b7f4-4cdf-8180-9bedd0af2704" name="dei:AmendmentFlag" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80">false</ix:nonNumeric><ix:nonNumeric id="F_a41af213-36a0-4e23-8e76-60218591669d" name="dei:EntityCentralIndexKey" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80">0001652130</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="ntla-20260511.xsd"/></ix:references><ix:resources><xbrli:context id="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001652130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-05-11</xbrli:startDate><xbrli:endDate>2026-05-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><h2 style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c3d94510-8c0e-4181-ba5d-fbe63e5825e4" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></h2><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_0781a661-2d9f-4f87-ab2e-080115cc842c" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">May 11, 2026</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ee2ad3b6-101b-4c4b-b074-b2df09ef08b3" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INTELLIA THERAPEUTICS, INC.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:18%;box-sizing:content-box;"/>
     <td style="width:41%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_7faba792-8d56-434b-a8d3-64f2f7d4e746" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_ab59e0e5-be67-42b3-9dae-630f724e87a5" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-37766</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_2f8ea93d-1250-4197-9b3c-7c056beeb1e7" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">36-4785571</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Commission File Number)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_e6de2da6-9376-43a0-b1da-5197f35b51e3" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">40 Erie Street, Suite 130</span></ix:nonNumeric></span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_a163851f-749a-4250-b266-67cc215f3b25" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cambridge</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_1dd3f271-92af-426b-9463-830fe138f8bf" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Massachusetts</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_327a670c-e90e-43fe-8f4a-32d2a393c13f" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">02139</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_fe0682f5-dc01-48b1-813c-0dd7575e8ce5" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">857</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_819282b1-dbbc-4be0-bb80-5730b5871a4c" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">285-6200</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_1ddca23a-574c-421d-9501-b82c463431c6" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:EntityInformationFormerLegalOrRegisteredName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Not Applicable</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:3pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b8940569-62ca-4793-a6af-c448a7026566" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_594c9792-4187-4d6a-b2ae-02261557878a" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6ca183dc-5c06-4e33-b16c-c21829b9964a" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6b878a60-f556-4f7b-83cc-04424c7f2f04" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:38%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:45%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Title of each class</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_bcda282b-c7de-4703-8baa-b503c349f2fb" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock, par value $0.0001 per share</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_157329c2-919c-45b3-a23d-9e09f9dc216b" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">NTLA</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_253ce72e-87f3-49ed-96fb-c124c717ae4c" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Nasdaq Global Market</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_006d5a87-8530-44dc-9d0c-72f4a883c7ec" contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h2 style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2.02 Results of Operations and Financial Condition.</span></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 11, 2026, Intellia Therapeutics, Inc. announced its financial results and business updates for the quarter ended March 31, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 on this Current Report on Form 8-K.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The information in this report furnished pursuant to Item 2.02 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended, if such subsequent filing specifically references the information furnished pursuant to Item 2.02 of this report</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><h2 style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) Exhibits</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:9%;box-sizing:content-box;"/>
     <td style="width:2.08%;box-sizing:content-box;"/>
     <td style="width:88.92%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:11pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No.</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    </tr>
    <tr style="height:6pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:11pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;99.1</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ntla-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Press release dated May 11, 2026.</span></a></p></td>
    </tr>
    <tr style="height:6pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:11pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;104</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:6%;box-sizing:content-box;"/>
     <td style="width:44%;box-sizing:content-box;"/>
     <td style="width:4%;box-sizing:content-box;"/>
     <td style="width:46%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intellia Therapeutics, Inc.</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 11, 2026</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ John M. Leonard</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name: John M. Leonard<br/>Title: Chief Executive Officer and President</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ntla-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-05-08T17:36:47.2610+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><img src="img149557450_0.jpg" alt="img149557450_0.jpg" style="width:715px;height:125px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#ff0000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> 												</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:13pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit 99.1</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Intellia Therapeutics Announces First Quarter 2026 Financial Results and Business Updates</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">-</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Presented positive Phase 3 HAELO topline clinical data for lonvo-z in HAE; initiated rolling BLA submission; anticipate U.S. launch in first half of 2027</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">-</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Recently resumed patient screening in MAGNITUDE and MAGNITUDE-2 Phase 3 clinical trials of nex-z in ATTR-CM and ATTRv-PN, respectively</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">-</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Including proceeds from underwritten public offering in April, existing cash resources expected to fund operations at least into 2028 </font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">CAMBRIDGE, Mass., May 11, 2026 &#x2013; Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today reported business updates and financial results for the first quarter ended March 31, 2026.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#34;It has been a remarkable start to 2026 for Intellia,&#34; said John Leonard, M.D., Intellia President and Chief Executive Officer. &#34;With lonvo-z, we achieved a historic milestone by presenting the world's first Phase 3 data for an </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> gene editing candidate and initiated a rolling BLA submission as we seek to provide a highly differentiated one-time treatment option to people living with HAE. We also recently resumed patient screening for both of our Phase 3 clinical trials in ATTR and strengthened our balance sheet with an underwritten public offering. We look forward to achieving additional important milestones during the remainder of the year.&#34;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Designed as a one-time treatment that is administered in an outpatient setting, lonvo-z is an </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> CRISPR gene editing candidate that is intended to inactivate the </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">kallikrein B1</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> (</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">KLKB1</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">) gene to permanently lower kallikrein and bradykinin levels and to eliminate HAE attacks.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:49.34%;box-sizing:content-box;"></td>
     <td style="width:50.66%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#7f7f7f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#7f7f7f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">1</font><font style="color:#7f7f7f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;of  5</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#999e9f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">intelliatx.com</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">In April, Intellia announced positive topline results from the global Phase 3 HAELO clinical trial of lonvo-z in HAE.</font></div></div><div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">-</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The trial met its primary endpoint. For the six-month efficacy evaluation period (weeks 5 to 28), a one-time infusion of lonvo-z reduced attacks by 87% versus placebo, with a mean monthly attack rate of 0.26 in the lonvo-z arm compared with 2.10 in the placebo arm (p&lt;0.0001). </font></div></div><div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">-</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The trial met all of its key secondary endpoints with statistical significance (p&lt;0.0001). These included a 62% rate of patients who were entirely attack free and therapy free in the lonvo-z arm for the six-month efficacy evaluation period, compared with 11% of patients in the placebo arm.</font></div></div><div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">-</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Favorable safety and tolerability data were observed for lonvo-z. The most common treatment emergent adverse events (TEAEs) during the primary observation period (infusion through week 28) were infusion-related reactions, headache and fatigue. All TEAEs reported as of the data cutoff (February 10, 2026) were mild or moderate (Grade 1 or Grade 2) and there were no serious adverse events observed in the lonvo-z arm. </font></div></div><div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.7033333333333336%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">-</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">As of the data cutoff, all patients who received lonvo-z at baseline or in crossover after week 28 remained free from long-term prophylaxis therapy.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Intellia announced in April that it has initiated a rolling biologics license application (BLA) submission to the U.S. Food and Drug Administration (FDA) to seek regulatory approval for lonvo-z. Pursuant to the regenerative medicine advanced therapy (RMAT) designation granted to lonvo-z by the FDA, a rolling BLA allows the company to submit portions of the BLA on an ongoing basis and provides the FDA with an opportunity to accelerate its review. Intellia plans to complete its BLA submission in the second half of 2026 to support a potential U.S. launch of lonvo-z in the first half of 2027.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">In the first quarter, Intellia presented several posters at the 2026 American Academy of Allergy, Asthma &amp; Immunology (AAAAI) Annual Meeting. The presentations included three-year follow-up data from patients receiving a one-time 50 milligram dose of lonvo-z and new survey findings assessing the chronic treatment burden and unmet needs among patients living with HAE.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Additional clinical data from HAELO will be presented at the 2026 European Academy of Allergy and Clinical Immunology Congress (EAACI), taking place June 12-15 in Istanbul, T&uuml;rkiye (abstract #100217).</font></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Nexiguran Ziclumeran (Nex-z) for Transthyretin (ATTR) Amyloidosis</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Nex-z is an investigational </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> CRISPR-based therapeutic candidate designed to inactivate the </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">TTR</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> gene in the liver, thereby preventing the production of transthyretin (TTR) protein. Nex-z offers the possibility of halting and reversing disease by driving a deep, consistent and potentially lifelong reduction in TTR protein after a one-time treatment. Intellia leads the development and commercialization of nex-z in collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron).</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">In the first quarter, the FDA lifted the clinical holds from the MAGNITUDE and MAGNITUDE-2 Phase 3 clinical trials of nex-z in ATTR amyloidosis with cardiomyopathy (ATTR-CM) and hereditary ATTR amyloidosis with polyneuropathy (ATTRv-PN), respectively. Patient screening activities are advancing in both trials. </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Intellia plans to complete patient enrollment in MAGNITUDE-2 in the second half of 2026.</font></div></div><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:49.34%;box-sizing:content-box;"></td>
     <td style="width:50.66%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#7f7f7f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#7f7f7f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">2</font><font style="color:#7f7f7f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;of 5</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#999e9f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">intelliatx.com</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Upcoming Events</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The company will participate in the following events during the second quarter of 2026:</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Bank of America Securities Health Care Conference, May 12, Las Vegas</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">RBC Capital Markets Global Healthcare Conference, May 20, New York</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Jefferies Global Healthcare Conference, June 3, New York</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">EAACI Congress, June 12-15, Istanbul, T&uuml;rkiye</font></div></div><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">First Quarter 2026 Financial Results</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:2.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:2.624473708711349%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Cash Position</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">: Cash, cash equivalents and marketable securities were $517.2 million as of March 31, 2026, compared to $605.1 million as of December 31, 2025.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Additionally, in April 2026, the company executed an underwritten public offering of its common stock for approximately $207 million in gross proceeds. The company&#x2019;s existing cash resources are expected to fund its operations at least into 2028 and well beyond lonvo-z&#x2019;s anticipated U.S. commercial launch for HAE in the first half of 2027. This guidance excludes all potential commercial revenues from lonvo-z.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:2.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:2.624473708711349%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Collaboration Revenue</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">: Collaboration revenue was $15.0 million for the first quarter of 2026, compared to $16.6 million for the first quarter of 2025.     </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:2.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:2.624473708711349%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">R&amp;D Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">: Research and development (R&amp;D) expenses were $80.7 million for the first quarter of 2026, compared to $108.4 million for the first quarter of 2025. The decrease was primarily driven by lower costs for research materials and contracted services, employee-related expenses, and stock-based compensation. Stock-based compensation expense included in R&amp;D expenses was $7.6 million for the first quarter of 2026.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:2.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:2.624473708711349%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">G&amp;A Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">: General and administrative (G&amp;A) expenses were $34.8 million for the first quarter of 2026, compared to $29.0 million for the first quarter of 2025. The increase was primarily driven by the ongoing buildout of the company&#x2019;s commercial infrastructure and higher legal expenses, partially offset by lower stock-based compensation. Stock-based compensation expense included in G&amp;A expenses was $5.9 million for the first quarter of 2026.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:2.624473708711349%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Net Loss</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">: Net loss was $96.2 million for the first quarter of 2026, compared to $114.3 million for the first quarter of 2025.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">About Intellia Therapeutics</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Intellia Therapeutics, Inc. (Nasdaq: NTLA) is a leading clinical-stage biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies. The company&#x2019;s mission is to transform the lives of people with severe diseases by developing and commercializing potentially curative treatments. With deep scientific, technical and clinical development experience, Intellia aims to reset the standard for medicine by durably treating the root causes of disease. Learn more at intelliatx.com and follow us @intelliatx.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Forward-Looking Statements</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">This press release contains &#x201c;forward-looking statements&#x201d; of Intellia Therapeutics, Inc. (&#x201c;Intellia&#x201d; or the &#x201c;company&#x201d;) within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, express or implied statements regarding Intellia&#x2019;s beliefs and expectations concerning: the success and advancement of its clinical programs for lonvoguran ziclumeran or &#x201c;lonvo-z&#x201d; (previously referred to as NTLA-2002) for the treatment of hereditary angioedema (&#x201c;HAE&#x201d;) and</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:49.34%;box-sizing:content-box;"></td>
     <td style="width:50.66%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#7f7f7f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#7f7f7f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">3</font><font style="color:#7f7f7f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;of 5</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#999e9f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">intelliatx.com</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">nexiguran ziclumeran or &#x201c;nex-z&#x201d; (previously referred to as NTLA-2001) for transthyretin (&#x201c;ATTR&#x201d;) amyloidosis, including its plan to complete the submission of a biologics license application (&#x201c;BLA&#x201d;) for lonvo-z in the second half of 2026, its expectations regarding review and approval of that BLA, including the potential for accelerated review, its expectations regarding a planned U.S. launch of lonvo-z in the first half of 2027, and its plans to complete patient enrollment in MAGNITUDE-2 of nex-z for hereditary ATTR amyloidosis with polyneuropathy in the second half of 2026; the potential of lonvo-z to inactivate the </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">KLKB1</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> gene to permanently lower kallikrein and bradykinin levels and to eliminate HAE attacks via a highly differentiated one-time treatment that is administered in an outpatient setting; the potential of nex-z to halt and reverse disease by driving a deep, consistent and potentially lifelong reduction in TTR protein after a one-time treatment; its ability to optimize the impact of its collaborations on its development programs, including, but not limited to, its collaboration with Regeneron Pharmaceuticals, Inc. (&#x201c;Regeneron&#x201d;) and their co-development program for ATTR amyloidosis; and its growth as a company and expectations regarding its uses of capital, expenses, future accumulated deficit and financial results, including its ability to fund operations at least into 2028 and well beyond lonvo-z&#x2019;s anticipated U.S. commercial launch for HAE in the first half of 2027.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Any forward-looking statements in this press release are based on management&#x2019;s current expectations and beliefs of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: uncertainties related to the conduct of clinical studies and other development and commercialization requirements for its product candidates, including lonvo-z and nex-z, including risks related to the ability to develop and successfully commercialize lonvo-z, nex-z or any of Intellia&#x2019;s product candidates; risks related to Intellia&#x2019;s ability to protect and maintain its intellectual property position; risks related to Intellia&#x2019;s relationship with third parties, including its contract manufacturers, collaborators, licensors and licensees; risks related to the ability of its licensors to protect and maintain their intellectual property position; uncertainties related to the authorization, initiation and conduct of preclinical and clinical studies and other development requirements for its product candidates, including uncertainties related to regulatory approvals to conduct clinical trials; risks related to the results of preclinical studies or clinical studies not being predictive of future results in connection with future studies; the risk that clinical study results will not be positive; risks related to the potential delay of planned clinical trials due to regulatory feedback or other developments; and risks related to Intellia&#x2019;s collaborations with Regeneron, or its other collaborations not continuing or not being successful. For a discussion of these and other risks and uncertainties, and other important factors, any of which could cause Intellia&#x2019;s actual results to differ from those contained in the forward-looking statements, see the section entitled &#x201c;Risk Factors&#x201d; in Intellia&#x2019;s most recent annual report on Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in Intellia&#x2019;s other filings with the Securities and Exchange Commission, including its quarterly report on Form 10-Q. All information in this press release is as of the date of the release, and Intellia undertakes no duty to update this information unless required by law.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:49.34%;box-sizing:content-box;"></td>
     <td style="width:50.66%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#7f7f7f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#7f7f7f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">4</font><font style="color:#7f7f7f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;of 5</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#999e9f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">intelliatx.com</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:1.6%;box-sizing:content-box;"></td>
     <td style="width:2%;box-sizing:content-box;"></td>
     <td style="width:11.158%;box-sizing:content-box;"></td>
     <td style="width:11.158%;box-sizing:content-box;"></td>
     <td style="width:25.435%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:20.556%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:2.14%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:21.956%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="11" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">INTELLIA THERAPEUTICS, INC.</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="11" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">CONSOLIDATED STATEMENTS OF OPERATIONS  (UNAUDITED)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="11" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">(Amounts in thousands, except per share data)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">2026</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td colspan="5" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Collaboration revenue</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">15,048</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">16,627</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="5" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Operating expenses:</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Research and development</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">80,737</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">108,427</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">General and administrative</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">34,843</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">29,007</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="3" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total operating expenses</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">115,580</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">137,434</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td colspan="5" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Operating loss</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(100,532</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(120,807</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="5" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Other income, net:</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Interest income</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">5,205</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">8,603</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Change in fair value of investments, net</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(904</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(2,125</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="3" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total other income, net</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">4,301</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">6,478</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td colspan="5" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Net loss</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(96,231</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(114,329</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td colspan="5" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Net loss per share, basic and diluted</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(0.81</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">(1.10</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td colspan="5" style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Weighted average shares outstanding, basic and diluted</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">118,490</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">103,500</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:53.92%;box-sizing:content-box;"></td>
     <td style="width:3.5%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:18.16%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:2.26%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:18.16%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">INTELLIA THERAPEUTICS, INC.</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">CONSOLIDATED BALANCE SHEET DATA  (UNAUDITED)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="8" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">(Amounts in thousands)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">March 31, 2026</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">December 31, 2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Cash, cash equivalents and marketable securities</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">517,247</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:Arial;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">605,134</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total assets</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">758,779</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">842,127</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total liabilities</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">137,840</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">170,733</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Total stockholders&#x2019; equity</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">620,939</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">671,394</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Investor Contact:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Jason Fredette</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Vice President, Investor Relations and Corporate Communications</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Intellia Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">jason.fredette@intelliatx.com</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Media Contact:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Mike Tattory</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Vice President</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">LifeSci Communications</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">mtattory@lifescicommunications.com</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:49.34%;box-sizing:content-box;"></td>
     <td style="width:50.66%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#7f7f7f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#7f7f7f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">5</font><font style="color:#7f7f7f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;of 5</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#999e9f;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">intelliatx.com</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img149557450_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img149557450_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "Y U(# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** /SZ_P""D?\ R0WPK_V5?0__ %$/'5?*/_!-S_DN7BK_ +)1
MKG_J7^!:^KO^"D?_ "0WPK_V5?0__40\=5\H_P#!-S_DN7BK_LE&N?\ J7^!
M:^@P_P#R)J__ '%_]*B?+XK_ )*##_\ <'_TF1]7?\%(_P#DAOA7_LJ^A_\
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M^/\ 183?V^G7MS:*]E;^(_#U[;W.J065S+';:OHEW-?Q0/X?\4:=<+I_V?\
M\/._^J(?^9*__ "OD;]IO]H^Q_:+OO"&J1_#NT\$ZGX9M-8L+O44UV'7[[7+
M'4)M/N-.LKF[7P[H5Q%::)<6^J3V5M+)>0K-KE_+ EJ\MPUUZ%&6/JU90Q>&
MIK#5%)-<U*7(K-Q3M.3FG91?N[M2]U(\NO'+*-"-3 XNJ\92<&I<E:'M'=*;
M7-3BJ;5W)+GV3B^9M'[U>!?&FA_$3P=X<\<>&[C[1HOB?2;35;+=+9RW%K]H
M0?:=-U#[!=7UI!JVDW:SZ7K%G%=W'V#5+.\LI)&EMWK^=K]OWQW^UKHW[6_Q
M9TWX9?L"?\+K\#VW_""?V)\3?^%3?M7^)O\ A)O.^&?@VXU+_B=_#3XG>'?!
M-[_8VKRW_A__ (DNCV?V;^ROLFI?:-6M[^ZG_6'_ ()VZYJFK? &\L-0NOM%
MIX8^(/B+0]#B\BWB^PZ7<:9X?\236OF00QRW._6O$.L7OGWCW%POVS[,LRVE
MO:P0>V^.+[X#0^*-4C\:?%__ (1;Q*OV+^TM"_X:.\9> OL.=.M&L_\ BD]*
M^(N@V&E?:K VMY_H^E6OV[[1_:4OGS7DES-\%Q%DV8YA"6!RO/\ -.'JU#%J
MJ\=E$*=3$U</&%6'U6HJKC'V,Y5:56;6JJT*:5TVS]D\.N,>'^%\:\YXEX"X
M:\0\%B\IG@X9)Q35Q-#+L+C:N)P==9I0EA+U'BZ-/"XC"4HR]QX?'8AR]Y11
MO_L[76O7W[/WP+O?%7A7_A!?%%Y\'/AC=>)/!'V#7=*_X0[7KCP5HDNL>%?[
M,\4WNI>)M-_X1[4'N-(^P>(M1O\ 7;/[']GU>]NM0CN)Y/EW_AIOX&_]'C_%
M?_PV?A#_ .ALK[OT%M+?0]%?0]0_M;17TG3FT?5?[8N/$/\ :>EM9PG3]0_M
M^\O-0N]<^V6AAN?[8NK^^N-3\S[;/>7,L[3/^7/_  R%^U#_ -!+]E'_ ,-'
M\//_ )P->UEM&E&E[/%XEU*E*G1@Z]=TXU*\XQE&I5FI4*ZYYR2G-1Y4I2?Q
M:6^*SS%U*^+J8K+\!3PU#%8G%UX8+"*M/#X*E5JJI1PM!QQ.&DZ-"$_94G/G
M;A33]UWYOU<K^>KX*_&KXR:K\9/A+I>J?%KXF:EIFI?$SP'8:CIU_P"//%-Y
M8W]C>>*=*M[NRO;2XU62WNK2ZMY)(+FVGCDAGAD>*5&1F4_T*U_,]\!O^2Y?
M!G_LJ_P[_P#4OT>O0RF,94L<Y1C)JG3MS).WNUMKK39;=CQ\[G.%;+N2<H\U
M6I?EDXW]_#[V:ON]^[/Z8:_"O0/V1?VJ/CE"/%?C:^N]+N(+2&PTN[^-'B3Q
M(?$5U8Q7VJK)96VG2V'B/Q%I-I87B7%R+;7+/1H;E=5AU#2$O[>[GN$_;/Q7
MXK\.^!_#NK^+?%NKVFA>'="M&O=4U2]9Q#;PATBC1(XDDN+J[NKB2&TL+"TA
MGOM1OI[:PL+:YO+F""3\N?B!_P %++YII;7X5_#NT@MX[NU>'6_B!=374UY8
MFQ8WMM+X7\.7MFFFW:ZG(JVMZOC#589+&U9YK".XOPFFXY=]<7M?JE*$G)P4
MJM1*U/EYKJ+;2O+F7,ES.R3Y=4UT9LL _8_7:]2"@JCC0I-\U5SY+2DHJ3Y8
M<CY6^5.3:YM'%_,_Q0_9%^-_P$T6#XCW=]X>O-,\/W=G?W/B/P1XDO8;[PI?
M+J^DV6AWI&K6'AO5_M=SJ^H6HTVY\/0ZE-936TMU>OIR1V\TWW?^P?\ M%>(
MOB?8^)/AW\0=<N]>\6^&;2RUOP]JU^J/?:CX1AAT_0[VTO;BTTF!+F[T+4QI
M]S<ZQK>JW^O^(9O%#O(9AI-U<M\^^+?VI/VN?&?PX\36^J? VT@\#^*_!.M0
MZCXHL/AG\38K&'PIKNA7*7>OV6MW'B&ZTB.TCTBZDU&VU6=;G34A5+N436H8
M-SW_  3<_P"2Y>*O^R4:Y_ZE_@6O1Q$:M; 8AXN-&5:C[U.I2<6TDT[.U^5W
MO%I64HM:*2YGY.%G1H9EA5@98B-"O[M2G7C*,6VFKQO;F5N647JXR3U<7RK]
MLZ***^:/KPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M);F+P]YFBOJ?A^.*[C37/[4OU?2[5&TS4M2T?X[_ .";G_)<O%7_ &2C7/\
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MHHKPSZ,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&.J8+^Q,%3P635:?">7T:.9TN(LZQ5//:M? 9CDV787.,CQLOJWXQ_&/X<?
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M)\?U8Y?Q%Q+_ *I<699P_A.'\@QV'PN?8C+,=B>)HXGB#$U%P]GW/@,L_L#
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MO!QEA\LQF/S3%8?!P_32BBBOH#\\"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M22W9K45Y1_POGX&_]%F^%'_AQ/"'_P N*],L+^QU6QLM4TN]M-2TS4K2VO\
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MU_!KXP_VS_PJ3XM_#+XI?\([_9__  D'_"N?'OA7QO\ V%_:_P!N_LK^V?\
MA&=5U/\ LS^T_P"S-2_L_P"V^1]M_L^^^S>;]DN/+U_$GQ+^''@R^BTOQA\0
M/!/A34Y[2._@T[Q)XKT+0KZ:QEFGMXKV*TU2_M;B2TDN+6Z@CN4C:%YK:>)7
M+PR*O;AZM+%TXU<+4IXFE/FY*F'G&M3GRR<9<LZ;E&7+*,HRLW:2:=FFCQ,?
M@\7E>(JX3,\+B,NQ='D]MA<?0JX3$4O:TX5:7M:.(C3J4_:4JD*D.>*YZ<X3
MC>,DWVU%<]X;\6^%/&=C+JG@_P 3>'O%>F07<EA/J/AO6M-UVQAOHH8+B6RE
MN]+N;JWCNX[>ZM9Y+9Y%F2&Y@E9 DT;-5TKQYX&U[7-2\,:'XS\)ZSXET;[9
M_;'A[2O$6CZCKFE?V=>1Z?J']I:39WDU_8_8;^:&QO/M5O%]EO)8[:?9,ZH=
MN67O>[+W?BT?N_XM-/F<O/#W??C[_P 'O+WO\.OO?*YU=%%<IXG\>>!O!'V'
M_A-/&?A/PC_:?VG^S?\ A)_$6CZ!_:'V+[/]L^P_VK>6GVO[)]KM?M/V?S/(
M^TV_F[/.CW))R=HIR;V23;?79:[:CE*,4Y2DHQ6[DTDKNRNW9*[T]3JZ*\H_
MX7S\#?\ HLWPH_\ #B>$/_EQ7H.N:]H?AC2[K7/$FM:3X>T6Q\C[;K&N:C9Z
M3I=G]IN(;.V^U:A?S6]I;_:+NX@M8/-F3S;B>&"/=+(BM3ISBTI0FG)VBG%I
MMZ:)-:O5;=T2JE.2DXU(245>34XM16KO)IV2LGJ^S[&M17*>&/'G@;QO]N_X
M0OQGX3\7?V9]F_M+_A&/$6CZ_P#V?]M^T?8_MW]E7EW]D^U_9+K[-]H\OS_L
MUQY6_P F3;U=2TXMJ2<6MTTTUUU3UVU*C*,DI1DI1>SBTT[.SLU=.ST]0HKS
M._\ C5\&]*OKW2]4^+7PSTW4]-N[FPU'3K_QYX6L[ZPOK.9[>[LKVTN-5CN+
M6[M;B.2"YMIXXYH)HWBE175E'IE.491MS1E&^W,FK^EUKNMNXHSA._).,N7?
MEDI6O>U[-VV>_9A1114E!17*>)_'G@;P1]A_X33QGX3\(_VG]I_LW_A)_$6C
MZ!_:'V+[/]L^P_VK>6GVO[)]KM?M/V?S/(^TV_F[/.CW5/#?Q+^''C.^ETOP
M?\0/!/BO4X+22_GT[PWXKT+7;Z&QBF@MY;V6TTN_NKB.TCN+JU@DN7C6%)KF
M")G#S1JU<D^7FY)<O\W*^71V>MK;Z;[D.I34N1S@IZ+D<H\UVKI<M[ZK5:;'
M;45SUSXM\*6?B*P\'W?B;P]:^+=5M'O]+\+W.M:;!XBU*QC6]>2]L-$EN5U.
M\M(TTW47>YM[62%5L+UF<"UG,?0TFFK735U=75KKNNZT>OD4FG>S3L[.S3L[
M)V?9V:=GK9H****0PHHHH **** "BBB@ HHHH **YO3/&7A#6_$/B?PCHWBK
MPWJ_BSP3_8O_  F?AC3-<TN_\0^$?^$DL9-3\._\)/HMK=2ZEH']OZ;%+J&B
M_P!JVUI_:MC%)=V/GVZ-(.DJ(5(5$Y4YPJ14ZE-RA)22G2G*E5@W%M*=.I"=
M.I'>$XRA)*46EK5HUJ$U"O2JT9RI4:T85:<J<Y4<31IXC#U5&:BW2KX>K2KT
M:B7+5HU*=6#E"<9,HKF_%WC+PA\/_#VH>+O'GBKPWX)\)Z1]D_M7Q/XNUS2_
M#?A[3/M]];:98_VAK6LW5EIME]MU*]L]/M/M-S%]IOKNVM(=]Q/%&^EHVLZ/
MXCT?2O$/A[5=-UW0-=TVQUG0]<T:^M=4T?6='U2UBOM,U72M3L99[+4=-U&R
MG@O+&^LYYK6[M9HKBWEDBD1RO:TG5=!5*?ME3C5='GC[54I2E"-1T[\ZIRG&
M48S:Y7*,HIW32IX;$K#1QCP]=8.=>>&CBG2J+#2Q-.G"K4P\:_+[)UX4JE.I
M.DI.I&G4A-Q49Q;TJ***T, HHHH **** "BBB@ HHHH **** "BBB@ HHKF]
M,\9>$-;\0^)_".C>*O#>K^+/!/\ 8O\ PF?AC3-<TN_\0^$?^$DL9-3\._\
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MRXMY8TBU7QYX&T'7--\,:YXS\)Z-XEUG['_8_A[5?$6CZ=KFJ_VC>2:?I_\
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ML1AZ=-2F](Q<KRZ)G=45RG_">>!O^$H_X0?_ (3/PG_PFO\ T*'_  D6C_\
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MC_@F)_S6_P#[IK_[O]>A_P R'^O^@P\O_FI?Z_Z #^;_ /X+%_\ *1W]HO\
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M<_\ 8*O_ $SBCY1_X)B?\UO_ .Z:_P#N_P!?JY7Y1_\ !,3_ )K?_P!TU_\
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MGC&Q\0:_?ZSX1_[!_P /K&\TSQ!<6.N>'O'_ ,+K;QQXX\4?$+PG%H=GYO\
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M,?LL_LR>+]2\>?!#X7?\(3XLU;PW>>$=0U7_ (3;XB^)/M'AZ_U31]9N]/\
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M4;F\-Z-X,TOPWKGACX2Z?XG^(OBGPAX*T2QT6Y\':]\)Y(_%.A>-K>P\*?\
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M %6/BBOR7_X)U?\ !.K]C?X[?L;_  >^*OQ5^#W_  E7CWQ5_P +!_M[7O\
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M?]J;X9_L7V'P?T7_ ()R?\+;^'7QR\-^(?%WB[QG_P ->_#KP%_PM'P]\8]
MAM;;4/\ A';N6_UWP3Y_POE\,>&/LFF:GI%]%_9/]M26VE^(;_4&'K7_  1<
M^+7BO3O"GQI_8T^)ZZ;I/CC]FGQMJRZ+H<NO>&I]8@T?6/$NOV/C_P .V.F:
M);EM;TWP'\2K'4+W5?&<6M^)K6>Z^)FC:.EUI^EVGAU-1_*. <REEW$N!JXQ
MYM3K>(6 S#,<RI8[*L\P>$H<2T<7B,WP>'PN*S? X7"5:<,@QE3+%/*ZU7#5
MYY1AY*FH5L+.7],^-N04\^\/\XP^51X9Q&%\"LYR3(<@Q&3\2\&YMFF,\/L5
ME> X7S7'9CEW#&=9GF>&KU>-\JH<0.CQ'A,-C\'1XHQL'7E6PF8TJ?I'_!;'
M6?B/H7['-A??#[5?&VC64_Q:\/Z-\2+OP;?:[IUK-\./$?@CXB>'M4TKQO<:
M)+#%)X)UW7]4\-:'?V.O.="U36-1T/3+B*>]N[""3S>Z_P""9W[$'[1WPX\&
M?$3]A/XAZ;\']?T7QMX=\46?QD\!^*/B3\4=8TF33M";7+?PG<Z#XA^+>D7O
MP]\;6%[KGA#Q3,;X:1XY\)W6F6=G=:;82ZA/Y7Z'?MG?M.?"']ECX0Q>+OC?
MX/\ $GCOP#X[\2)\*M0\,>'/#_ACQ/\ VK_PD_ACQ3J=W9Z]HOB[7_#VBWWA
MN^T7P]JVGZI;SW-Y]I^V06DNG7%I<7,D'Y+_ /!1;]D+]FSX$? VW_;/_90\
M7_\ #/\ \1;+Q)INM>$=9^%'Q!U:RT/XLV/Q>N(+&YTSX=2VGBM+?PW]D\*:
MOK?BWP['\*'L_#S_  \LO%NE3>&+WP]-I^J^$_1XWRW+8YOQ-G6*R_(^*\+@
MLCRNOG62X[%5,OS[(<)A)8VK',.'LPC2J*C+&4'5K5\/2K9?7Q-7!484L8ZL
MZ5&7A>#^?9_/A?P]X1RW.^,O#3,<XXRXDP?"7%N39=A\\X+XTS/,X91AYY'Q
MUD4\30EBJ658N.'PN#QN)PN=X+ 8?.,76Q&5+#T\3B:?]!6C1:Q!H^E0>(;[
M3=4U^'3;&+7-3T;2KK0M'U'6([6)-3OM*T.^UGQ'>Z-IMW>B>XL=*O/$.NW6
MG6LD5G<:SJDL+WT_\^L_[.OP;_:;_P""R_[6W@/XW^#O^$V\)Z1\$_!GB[3]
M*_X2'Q3X;^S^(;#P7^S=HUIJ'V[PCKF@:E+Y6FZ_JUM]DGO);&3[7YTML]Q!
M;2P_MA^S3XN\0_$#]G+X >//%VH?VOXL\;?!/X5>+O$^J_9+&P_M/Q#XD\":
M#K.M:A]ATRVLM-LOMNI7MS<_9-/L[2QMO-\FTMH+=(XD_$^?]G7X-_M-_P#!
M9?\ :V\!_&_P=_PFWA/2/@GX,\7:?I7_  D/BGPW]G\0V'@O]F[1K34/MWA'
M7- U*7RM-U_5K;[)/>2V,GVOSI;9[B"VEA]CQ 5/-<NX ='+\)F5+'\89/4I
M9=G53DPF)IULASRK"CCZGU7-;+E:=27U7&7FOAG?F/E/ Z=?AK/O&Y8K/,TX
M>Q.3>%G%-#$9]PE057-,NKX3C;@W#UL5DF'69<-J4O:1DJ$%F.5)49VYZ5O9
MO]C/V?/V1OV>OV6/^$N_X4-\/O\ A!/^$[_L#_A*O^*K\;^)_P"U?^$8_MK^
MP_\ D<O$OB'[#]A_X2'6/^0;]C^T_;/],^T?9[7R/I"OF_\ 9\_9&_9Z_98_
MX2[_ (4-\/O^$$_X3O\ L#_A*O\ BJ_&_B?^U?\ A&/[:_L/_D<O$OB'[#]A
M_P"$AUC_ )!OV/[3]L_TS[1]GM?(^D*_0<EPGU#+,-A/[+RK)?9>V_X3,EJ>
MURS#>TQ%6I_LU3^SLIYO;<_UBM_PGX>V(JU8_O;>WJ?AG%V:?VUQ#F&9_P"L
M?$G%OUGZI_QD/%U#ZMQ#F'L<#AL/_P *%#^WN)N3ZI[+ZCA/^%S'<V!PV&G_
M +-S?5,.4445ZI\V?S/?'G_DN7QF_P"RK_$3_P!2_6*_5S_@FY_R0WQ5_P!E
M7US_ -1#P+7Y1_'G_DN7QF_[*O\ $3_U+]8K]7/^";G_ "0WQ5_V5?7/_40\
M"U]1F7_(MA_W _)'QN4?\C:I_P!S/_I3/Q,K^KBOY1Z_JXKGSW_F%_[C_P#N
M$ZN&_P#F-_[EO_<Y_,O_ ,['/^?^C$Z/^#B[_FSO_NX/_P!XA1_SL<_Y_P"C
M$Z/^#B[_ )L[_P"[@_\ WB%?R/F__)N?&+_LYF9_^KWAT_UDX/\ ^4DOH:?]
MHP\+_P#K!>(Y^FG_  1T_P"4<7[.G_=7?_5[?$^N7_:K_P"3X_V;O^Z/?^K>
M\15U'_!'3_E'%^SI_P!U=_\ 5[?$^N7_ &J_^3X_V;O^Z/?^K>\15_07AQ_R
M2O"O_9(Y1_ZI\*?Y_?2$_P"3O>+/_9V>-O\ UK\U.H_X+%_\HXOVB_\ ND7_
M *O;X85_#'7]SG_!8O\ Y1Q?M%_]TB_]7M\,*_ACK^5_'_\ Y+++/^R9P?\
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M7/\ U$/ M?H+7EYA_ON(_P"OC_)'LY7_ ,B_"?\ 7I?FS\H_VJ_^3X_V;O\
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MFWQ+_P"SFO&7_JK/@Q7\?M?V!?\ !OW_ ,F;?$O_ +.:\9?^JL^#%?F?@?\
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M,:L*="$(5H\E6*3M.-I*TM=K3DOFSY]^!/[-O@;]GO\ X2K_ (0O5?%FI_\
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M0IUHTL-FGLL)A*?]H48PQ?L\+AX>VY:--1\W^$?PC^'GP)^'GA_X5?"KP_\
M\(KX"\*_VM_8.@_VMKFN?8/[<US4O$>J?\33Q'J6L:U=?:M:UC4;S_3-1N/(
M^T?9[?R;2&""+Q/X\_L,?LL_M-^+]-\>?&_X7?\ ";>+-)\-V?A'3]5_X3;X
MB^&_L_AZPU36-9M-/^P^$?%V@:;+Y6I:_JUS]KGLY;Z3[7Y,MR]O!;10_6E%
M8XC)LHQ> I95B\JRW$Y90A1IT<NQ&!PM; 488:*AAX4L'4I2P].&'A%0HQA3
M2I12C344DCLP/%G%.5YUB>),LXEX@R[B+&5<76Q>?X'.<QPF=8JMF%257'U<
M3FF'Q-/'5ZN-JSE5Q=2K7E+$U)2G6<Y-M_)?P&_88_99_9D\7ZEX\^"'PN_X
M0GQ9JWAN\\(ZAJO_  FWQ%\2?:/#U_JFCZS=Z?\ 8?%WB[7]-B\W4M TFY^U
MP6<5]']D\F*Y2WGN8IOJ+6=&T?Q'H^J^'O$.E:;KN@:[IM]HVN:'K-C:ZIH^
MLZ/JEK+8ZGI6JZ9?13V6HZ;J-E//9WUC>036MW:S2V]Q%)%(Z'2HK3 Y7EF6
M85X++<NP.7X)N<GA,#A,/A,*Y5?XDGAZ%.G2O4^V^2\_M7,,XXBX@XAS%9QG
M^>YSGF;*-&"S3.,TQN9YBH8?_=X+'8VO7Q*C0_Y<Q]K:E]A1/SQT;_@E'_P3
M_P!"UC2M<L?V>--GO=&U*QU6S@UGQ]\5_$>CS76G745Y;Q:KX>\0^.]4T#7=
M-DEA1+[1M<TS4='U2U,MCJ=C=V4\]O)]^:-HVC^'-'TKP]X>TK3="T#0M-L=
M&T/0]&L;72]'T;1]+M8K'3-*TK3+&*"RT[3=.LH(+.QL;."&UM+6&*WMXHXH
MT0:5%89;D>29-[7^R,GRK*O;6]M_9N7X3 ^UY?A]K]5HTO:<O3GO;H=>?\9<
M7\6?5_\ 6GBKB3B7ZIS?5?[?SS-,Y^K<_P ?U?\ M'%8GV//]KV?+S=;GR[\
M?OV+?V8OVH-8\/\ B'XY?"G3?&NO^&--NM&T?7(M=\6^%-8CT>ZNA?'2K[4_
M!7B#PY>ZSIMI>FYO-*L=9GU"UT6ZU+6;C2(K&76]8>^/@#^Q;^S%^R_K'B#Q
M#\#?A3IO@K7_ !/IMKHVL:Y+KOBWQ7K$FCVMT;X:58ZGXU\0>([W1M-N[T6U
MYJMCHT^GVNM76FZ-<:O%?2Z)H[V/U%14_P"K^0_VE_;']B91_:_/[3^U?[-P
M7]I<_LO8\_U[V/UKG]C^ZYO:W]E^[OR:&O\ KQQK_8'^JG^N'%/^J_LO8_ZM
M_P"L&;?V!['ZQ];]E_8_UO\ L[V7UK_:?9_5N7ZQ^^M[3W@HHHKUSY8\3T/]
MG7X-^&_CEXR_:2T7P=]B^-/Q \-VOA'Q=XS_ .$A\4W/]K^'K*W\*VMMI_\
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M_!.K]C?X[?$/Q!\5?BK\'O\ A*O'OBK^R?[>U[_A8/Q3T/[?_8>AZ;X<TO\
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>(0YYNI/EBH\\Y6YIRLES3E97D[MV5V%%%%26?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>ntla-20260511.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2026-05-08T17:36:47.9899+00:00 -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://intelliatx.com/20260511" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:ntla="http://intelliatx.com/20260511" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" namespace="http://fasb.org/us-gaap/2025"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="ntla-20260511.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Information, Former Legal or Registered Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="10150.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>May 11, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 11,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INTELLIA THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001652130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-4785571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">40 Erie Street, Suite 130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">285-6200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Not Applicable<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NTLA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ntla-20260511.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ntla-20260511.htm">ntla-20260511.htm</File>
    <File>ntla-20260511.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>12
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ntla-20260511.htm": {
   "nsprefix": "ntla",
   "nsuri": "http://intelliatx.com/20260511",
   "dts": {
    "inline": {
     "local": [
      "ntla-20260511.htm"
     ]
    },
    "schema": {
     "local": [
      "ntla-20260511.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ntla-20260511.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ntla-20260511.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://intelliatx.com/20260511/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0001193125-26-215721-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-215721-xbrl.zip
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MK5ZM6?]GF7^,^F\(]:+E7R3+ON5N-&C6[1J<0@($NXQ_P,#O1H78'XZ>+7?
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M2Z_''1::1 [W;QX-4O7<(+>,4 >>'P,&4C( /AZ$P.1AFPQ^!6KH3D F2#,
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MF48N?Z 7JPP#QXF'L4J"<EF/.UR=7B^KOTDN8YR7!+D#D=G91<C,UK[^W=&
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MAOS^73=P)[_^[?V[033T?OU_4$L! A0#%     @ ASRK7"G^21@)%   RKL
M !$              ( !     &YT;&$M,C R-C U,3$N:'1M4$L! A0#%
M  @ ASRK7*>I,/*N"   OF$  !$              ( !.!0  &YT;&$M,C R
M-C U,3$N>'-D4$L! A0#%     @ ASRK7%FGJ@3,(@  "/H!  \
M     ( !%1T  &YT;&$M97@Y.5\Q+FAT;5!+!08      P # +L    .0
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>ntla-20260511_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ntla-20260511.xsd" xlink:type="simple"/>
    <context id="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001652130</identifier>
        </entity>
        <period>
            <startDate>2026-05-11</startDate>
            <endDate>2026-05-11</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_a664bd6f-b7f4-4cdf-8180-9bedd0af2704">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_a41af213-36a0-4e23-8e76-60218591669d">0001652130</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_c3d94510-8c0e-4181-ba5d-fbe63e5825e4">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_0781a661-2d9f-4f87-ab2e-080115cc842c">2026-05-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_ee2ad3b6-101b-4c4b-b074-b2df09ef08b3">INTELLIA THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_7faba792-8d56-434b-a8d3-64f2f7d4e746">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_ab59e0e5-be67-42b3-9dae-630f724e87a5">001-37766</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_2f8ea93d-1250-4197-9b3c-7c056beeb1e7">36-4785571</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_e6de2da6-9376-43a0-b1da-5197f35b51e3">40 Erie Street, Suite 130</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_a163851f-749a-4250-b266-67cc215f3b25">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_1dd3f271-92af-426b-9463-830fe138f8bf">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_327a670c-e90e-43fe-8f4a-32d2a393c13f">02139</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_fe0682f5-dc01-48b1-813c-0dd7575e8ce5">857</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_819282b1-dbbc-4be0-bb80-5730b5871a4c">285-6200</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_1ddca23a-574c-421d-9501-b82c463431c6">Not Applicable</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_b8940569-62ca-4793-a6af-c448a7026566">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_594c9792-4187-4d6a-b2ae-02261557878a">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_6ca183dc-5c06-4e33-b16c-c21829b9964a">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_6b878a60-f556-4f7b-83cc-04424c7f2f04">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_bcda282b-c7de-4703-8baa-b503c349f2fb">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_157329c2-919c-45b3-a23d-9e09f9dc216b">NTLA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_253ce72e-87f3-49ed-96fb-c124c717ae4c">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_c4ed5b8f-b50c-48f4-b9b0-7e4b43789e80"
      id="F_006d5a87-8530-44dc-9d0c-72f4a883c7ec">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
